Corcept Therapeutics (CORT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $22.21 --0%
Revenue Growth %: +33.2%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: +33.2%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $13.3 million versus the consensus estimate of $13.9 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Chevron (CVX) Misses Q1 EPS by 3c
- Chevron (CVX) earnings fall short while revenue tops estimates in Q1
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
